Glenmede Trust CO Na Cara Therapeutics, Inc. Call Options Transaction History
Glenmede Trust CO Na
- $18.2 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CARA
# of Institutions
8Shares Held
797KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$11.9 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$645,1830.02% of portfolio
-
Rothschild Investment Corp10.6KShares$169,1760.0% of portfolio
-
Ahrens Investment Partners LLC700Shares$11,1720.0% of portfolio
-
Benjamin F. Edwards & Company, Inc. St. Louis, MO500Shares$7,9800.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $857M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...